Your session is about to expire
← Back to Search
Home Blood Pressure Monitoring for High Blood Pressure Control in Stroke Patients
N/A
Recruiting
Led By Liron D Kraler, MD
Research Sponsored by Stanford University
Eligibility Criteria Checklist
Specific guidelines that determine who can or cannot participate in a clinical trial Must have
Participant or surrogate able to apply a home blood pressure cuff on the participant
Be older than 18 years old
Timeline
Screening 3 weeks
Treatment Varies
Follow Up months 3 and 6
Awards & highlights
Study Summary
This trial aims to see if providing a free home blood pressure monitor can help control hypertension, especially for disadvantaged patients, and reduce negative health outcomes.
Who is the study for?
This trial is for adults over 18 who've been treated at Stanford Hospital's stroke service and are going home or to acute rehab. They must have had a stroke, mini-stroke, or be at risk of stroke with high blood pressure but don't own a blood pressure cuff. They can't join if they're in another similar study or have an upper arm larger than 20 inches.Check my eligibility
What is being tested?
The study tests if giving patients a free home blood pressure monitor and teaching them how to use it helps control high blood pressure better than just routine education. It also checks if this approach works well for disadvantaged groups and reduces negative health outcomes.See study design
What are the potential side effects?
Using the Omron Home Blood Pressure Cuff generally doesn’t cause side effects; however, incorrect use might lead to inaccurate readings which could affect treatment decisions.
Eligibility Criteria
Inclusion Criteria
You may be eligible if you check “Yes” for the criteria belowSelect...
I or someone I trust can use a home blood pressure monitor on me.
Timeline
Screening ~ 3 weeks3 visits
Treatment ~ Varies
Follow Up ~ months 3 and 6
Screening ~ 3 weeks
Treatment ~ Varies
Follow Up ~months 3 and 6
Treatment Details
Study Objectives
Outcome measures can provide a clearer picture of what you can expect from a treatment.Primary outcome measures
Blood pressure
Secondary outcome measures
Any hospitalization
Incidence of TIA
Incidence of stroke
Trial Design
2Treatment groups
Experimental Treatment
Active Control
Group I: Access to Blood Pressure MonitoringExperimental Treatment1 Intervention
Participants will also receive the teaching administered to the control group. In addition, they will be given an Omron Home Blood Pressure Cuff furnished by the study. The nurse will provide additional education on on how to use the cuff, and how to record values in a blood pressure log.
Group II: Standard of CareActive Control1 Intervention
Participants will receive routine stroke discharge education which is standard of care. A stroke nurse will provide and review with the patient a short informational pamphlet on the importance of blood pressure monitoring.
Find a Location
Who is running the clinical trial?
Stanford UniversityLead Sponsor
2,395 Previous Clinical Trials
17,341,300 Total Patients Enrolled
Liron D Kraler, MDPrincipal InvestigatorStanford University
Christina M Mijalski Sells, MDPrincipal InvestigatorStanford University
Media Library
Eligibility Criteria:
This trial includes the following eligibility criteria:- I, or my legal representative, agree to participate and can give consent.My upper arm is larger than 20 inches in circumference.I or someone I trust can use a home blood pressure monitor on me.I am over 18, was treated for a stroke at Stanford Hospital, and am going home or to acute rehab.I have been diagnosed with high blood pressure.You do not have a working blood pressure cuff at home.I have had a stroke, TIA, or am at high risk for a stroke as determined by my doctor.
Research Study Groups:
This trial has the following groups:- Group 1: Standard of Care
- Group 2: Access to Blood Pressure Monitoring
Awards:
This trial has 1 awards, including:- No Placebo-Only Group - All patients enrolled in this study will receive some form of active treatment.
Timeline:
This trial has the following timeline:- Screening: It may take up to 3 Weeks to process to see if you qualify in this trial.
- Treatment: The duration you will receive the treatment varies.
- Follow Ups: You may be asked to continue sharing information regarding the trial for 6 Months after you stop receiving the treatment.
Frequently Asked Questions
These questions and answers are submitted by anonymous patients, and have not been verified by our internal team.
Is the research team currently recruiting participants for this trial?
"Clinicaltrials.gov shows that this research endeavour, which was first made known on March 1st 2023 and had its most recent update two weeks later, is no longer recruiting patients to take part in the study. Nevertheless there are other trials still welcoming volunteers; 1848 of them at present."
Answered by AI
Share this study with friends
Copy Link
Messenger